BIND Biosciences secures Series C-1 financing - MarketLine Financial Deals

BIND Biosciences secures Series C-1 financing

BIND Biosciences secures Series C-1 financing - MarketLine Financial Deals
BIND Biosciences secures Series C-1 financing
Published Jun 29, 2010
3 pages — Published Jun 29, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

BIND Biosciences, Inc., a US-based biopharmaceutical company that develops therapeutic targeted nanoparticles to produce drugs, has secured Series C-1 financing.

  
Source:
Document ID
MA27788_100701
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "BIND Biosciences secures Series C-1 financing" Jun 29, 2010. Alacra Store. Dec 08, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/BIND-Biosciences-secures-Series-C-1-financing-2052-35895>
  
APA:
MarketLine Financial Deals. (2010). BIND Biosciences secures Series C-1 financing Jun 29, 2010. New York, NY: Alacra Store. Retrieved Dec 08, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/BIND-Biosciences-secures-Series-C-1-financing-2052-35895>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.